2nd Circ. Skeptical Of Reviving Investors' Breast Implant Suit
The Second Circuit on Wednesday wondered whether there was enough evidence to revive a class action lawsuit accusing Allergan Ltd. of downplaying cancer risks linked to the company's breast implants, with...To view the full article, register now.
Already a subscriber? Click here to view full article